SF3B4
protein-codingsplicing factor 3b subunit 4, the group of SF3b complex|RNA binding motif containing
Gene summary
This gene encodes one of four subunits of the splicing factor 3B. The protein encoded by this gene cross-links to a region in the pre-mRNA immediately upstream of the branchpoint sequence in pre-mRNA in the prespliceosomal complex A. It also may be involved in the assembly of the B, C and E spliceosomal complexes. In addition to RNA-binding activity, this protein interacts directly and highly specifically with subunit 2 of the splicing factor 3B. This protein contains two N-terminal RNA-recognition motifs (RRMs), consistent with the observation that it binds directly to pre-mRNA. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~4.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007943
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007943
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0800483
Submitter: ClinGen
*SF3B4* was first reported in relation to autosomal dominant SF3B4-related acrofacial dysostosis in 2012 (Bernier et al., PMID: 22541558). SF3B4 has been noted to be associated with the following disease entities: Nager acrofacial dysostosis and Rodriguez acrofacial dysostosis. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity, SF3B4-related acrofacial dysostosis (MONDO:0800483). Six variants (1 start-loss, 4 frameshift, 1 nonsense) that have been reported in 11 probands in 2 publications (PMID: 22541558, PMID: 23568615) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be LOF. This gene-disease association is also supported by experimental evidence (animal models and expression level evidence) (PMID: 26874011, 31900962, 9097020). SF3B4 KD Xenopus models and heterozygous SF3B4 mutant mice models demonstrated some features of Nager syndrome (PMID: 26874011, 31900962). Additionally, the gene has been shown to be expressed in areas of interest in mice (PMID: 9097020). In summary, *SF3B4* is definitively associated with autosomal dominant SF3B4-related acrofacial dysostosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations Gene Curation Expert Panel on 05/18/2023. (Gene Clinical Validity Standard Operating Procedures Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0007943
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007943
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007943
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008714
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SF3B4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005850.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 33 | 2 | 41 | |
| missense | 45 | 7 | 52 | |||
| nonsense | 8 | 1 | 2 | 11 | ||
| start loss | 3 | 3 | ||||
| frameshift | 27 | 7 | 1 | 35 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 2 | 6 | ||
| Total | 41 | 10 | 55 | 40 | 2 | 148 |
Highest pathogenic variant AF is 0.000014550216
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005841.1 | 6 | MANE Select | |
| Ensembl | ENSP00000271628.8 | 6 | MANE Select | |
| Ensembl | ENSP00000391114.1 | 2 | Standard | |
| Ensembl | ENSP00000610823.1 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| sf3b4 | Danio rerio | Structure: trunk Quality: necrotic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Spliceosome - Homo sapiens (human)
- mRNA Processing
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- mRNA Splicing - Minor Pathway
Biological Process
- RNA splicing, via transesterification reactions
- mRNA splicing, via spliceosome
- mRNA processing
- RNA splicing
- positive regulation of mRNA splicing, via spliceosome
Molecular Function
- RNA binding
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- spliceosomal complex
- U12-type spliceosomal complex
- nucleolus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000271628
- Coding exons
- 6
- Length
- 5028
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.87 | 70 | 238 | 0.294 | 0.0000126 | 2708 |
| Missense (PolyPhen) | 2 | 55.307 | 0.036161 | 651 | ||
| Synonymous | -0.651 | 97 | 89.2 | 1.09 | 0.00000466 | 944 |
| Loss of Function | 3.51 | 0 | 14.4 | 0.00 | 9.36e-7 | 161 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex. SF3B4 has been found in complex 'B' and 'C' as well (PubMed:10882114). Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron (PubMed:15146077). {ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:27720643}.;
- Disease
- DISEASE: Acrofacial dysostosis 1, Nager type (AFD1) [MIM:154400]: A form of acrofacial dysostosis, a group of disorders which are characterized by malformation of the craniofacial skeleton and the limbs. The major facial features of AFD1 include downslanted palpebral fissures, midface retrusion, and micrognathia, the latter of which often requires the placement of a tracheostomy in early childhood. Limb defects typically involve the anterior (radial) elements of the upper limbs and manifest as small or absent thumbs, triphalangeal thumbs, radial hyoplasia or aplasia, and radioulnar synostosis. Phocomelia of the upper limbs and, occasionally, lower-limb defects have also been reported. {ECO:0000269|PubMed:22541558}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- RVIS EVS
- -0.3
- RVIS percentile EVS
- 32.62
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.995
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Low | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Low | Low | Low |